Pricing Log in Create free account

Alzamend Neuro, Inc. (ALZN) vs Traws Pharma, Inc. (TRAW)

Alzamend Neuro, Inc. and Traws Pharma, Inc. are both Biotechnology companies. Alzamend Neuro, Inc. and Traws Pharma, Inc. are of similar size ($6.2M and $6.2M). Across the 9 metrics below, Alzamend Neuro, Inc. leads on 6 and Traws Pharma, Inc. on 3.

Valuation

Metric ALZN TRAW Biotechnology median
P/E n/m n/m 8.50
P/S n/m 2.06 9.71
P/B 1.02 3.47 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.15 n/m 0.64
EV/Sales n/m 0.30 9.21
Earnings yield (174.24%) (475.68%) (33.15%)
Free cash flow yield (120.83%) (287.29%) (25.50%)

Profitability

Metric ALZN TRAW Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.23%) (319.42%) (56.36%)
Return on assets (122.36%) (117.35%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALZN TRAW Biotechnology median
Revenue growth (TTM) — 1,159.29% 6.02%
EPS growth (last fiscal year) 76.77% 100.76% 30.26%
Revenue growth, 5-year CAGR — 64.59% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALZN TRAW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.01 0.93 4.72
Net debt to EBITDA 0.08 0.21 0.96

Dividend

Metric ALZN TRAW Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ALZN TRAW Biotechnology median
Market cap 6.17m 6.20m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack